Brief: Xortx Announces Grant Of U.S. Patent
07/04/2022 12:15
April 7 (Reuters) - XORTX Therapeutics Inc XRTX.V :
* XORTX ANNOUNCES GRANT OF US PATENT
* XORTX THERAPEUTICS- ANNOUNCED RECEIPT OF NOTIFICATION THAT
PATENT "FORMULATIONS OF XANTHINE OXIDASE INHIBITORS" WILL BE
GRANTED BY U.S. PATENT OFFICE
Source text for Eikon: ID:nGNX4Y0zjf
Further company coverage: XRTX.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on XORTX Therapeutics
See all newsBrief: Xortx Outlines Anticipated Health Canada Clinical Trial Application For Xrx-026 For Gout
Brief: XORTX Therapeutics Announces Initiation Of Drug And Tablet Manufacturing For XRx-026 Program
Brief: Xortx Announces Termination And Postponement Of Investor Relations Program
Brief: XORTX Announces Director Resignation
Brief: Xortx Announces Us$5 Million Public Offering